Soluble human complement receptor type 1 inhibits complement-mediated host defense.

Soluble complement receptor type 1 (sCR1) is a powerful inhibitor of complement activation. Because of this ability, sCR1 may prove to be an important therapeutic agent that can be used to block the immunopathologic effects of uncontrolled complement activation in a variety of clinically significant...

Descrición completa

Detalles Bibliográficos

Publicado en:	Clin Diagn Lab Immunol
Principais autores:	Swift, A J, Collins, T S, Bugelski, P, Winkelstein, J A
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1994
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC368344/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8556505/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.1.5.585-589.1994
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!